Landmark decision by the World Health Organization’s Executive Board to approve a WHA resolution on hemophilia and other bleeding disorders resolution

Landmark decision by the World Health Organization’s Executive Board to approve a WHA resolution on hemophilia and other bleeding disorders

On February 3rd, 2026, the Executive Board of the World Health Organization (WHO), in a landmark decision, approved a resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders, which will now be presented at the 79th World Health Assembly on May 18 to 23, 2026 for final adoption.

Also available in: Français Español

The WFH applauds the WHO Member States—especially the government of Armenia, and the co-sponsors Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo—that have been leading efforts for the adoption of a dedicated WHA resolution. Additional Member States also expressed their strong support for the adoption of this resolution during the discussions at the WHO Executive Board on February 2 and 3, 2026.

What is a World Health Assembly Resolution?

A World Health Assembly Resolution is an official WHO policy document adopted by the WHO Member states to set global health priorities and policies, guide national health strategies and request specific actions from the WHO Secretariat. Although not legally binding under international law, these resolutions represent a significant international policy instrument and a political commitment, as they are adopted by the consensus of all the WHO Member States.

What impact can the resolution have?

By adopting the WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders, the WHO and its Member States (national governments) will recognize bleeding disorders as a global health priority and take critical step towards developing a coordinated global framework and concrete actions to address the health inequities affecting our community. The resolution includes three main sections:

  • Section 1 is the preamble that highlights key disparities that people with bleeding disorders face in terms of underdiagnosis and inequitable access to treatment and care, regardless of type of bleeding disorder, gender or where they live. It also outlines already-existing key United Nations (UN) and WHO international policy documents that the proposed resolution is in alignment with.
  • Section 2 includes the main recommendations that the resolution urges all Member States to implement at the country level, focusing on the introduction of relevant policies and programs directed towards improving diagnosis; equitable access to treatment, including sustainable financing and access to prophylaxis and home treatment programs; comprehensive care; data collection; awareness-raising and other interventions, including on women and girls with bleeding disorders; as well as the promotion of the celebration of World Hemophilia Day; and establishing consultative mechanisms for engagement with local civil society organizations representing the inherited bleeding disorders community.
  • Section 3 outlines concrete actions for the WHO to implement, including the development of recommendations for member states, the recognition of World Hemophilia Day as an official WHO global health day for all bleeding disorders, and biennial reporting on progress made by member states towards implementing the resolution.

To read the full text of the draft resolution, click here.

Landmark decision by the World Health Organization’s Executive Board to approve a WHA resolution on hemophilia and other bleeding disorders resolution - Proceedings at the WHO office.
158th session of the WHO Executive Board.
Landmark decision by the World Health Organization’s Executive Board to approve a WHA resolution on hemophilia and other bleeding disorders resolution - Members of the Armenian Society of Hemophilia and the WFH
Members of the Armenian government delegation and the WFH

The journey to resolution approval

In preparation for the discussion at the WHO 158th Session of the Executive Board, the WFH launched a Global Call for Health Equity for Bleeding Disorders. Since the launch, 86 national, regional and international patient, medical and scientific organizations have joined the Global Call. The WFH expresses its sincere appreciation to all national member organizations (NMOs) and collaborating organizations for joining the Global Call and for demonstrating strong support and solidarity for this historic global initiative.    

On January 29, 2026, the WFH also presented an open letter to Dr. Tedros Adhanom Ghebreyesus, MD, the WHO Director-General, calling for the adoption of the resolution. To read the letter, please click here.

The WFH also participated at the 158th session of the WHO Executive Board and delivered a powerful statement urging the WHO and its Member States to adopt the resolution. The WFH statement can be viewed below:

Next steps

The next and final step in the process is the adoption of the resolution at the 79th World Health Assembly scheduled to take place from May 18 to 23, 2026.

The WFH will continue to actively advocate with the member states to support this resolution, as well as invite more organizations to join our Global Call.

The WFH is also developing a dedicated page on our website with key information related to the WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and other Bleeding Disorders, as well as a toolkit for organizations wishing to engage and further support this initiative. These resources will be made available shortly.

To find out more about the WFH Global Call in support of the WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and other Bleeding Disorders, please read the announcement here or contact the WFH directly at [email protected]. To get an overview of WFH advocacy efforts, click here.

Landmark decision by the World Health Organization’s Executive Board to approve a WHA resolution on hemophilia and other bleeding disorders resolution
Left to right: Rana Saifi, Regional Manager, Middle East, WFH; Salome Mekhuzla, Director, Global Development, WFH; Karine Kocharyan, WFH Regional Manager, Europe and Central Asia, WFH at the WHO Headquarters.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.